Skip to content

1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)

A 52-week Treatment, Randomized, Double-blind, Placebo-controlled, With Open-label Tiotropium, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Patients With Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00929110
Acronym
GLOW2
Enrollment
1066
Registered
2009-06-26
Start date
2009-06-30
Completion date
2011-04-30
Last updated
2012-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD, NVA237, glycopyrronium bromide

Brief summary

This study was designed to investigate the 1 year efficacy and safety of the 50 µg once daily (od) dose of glycopyrronium bromide (NVA237) in patients with moderate to severe chronic obstructive pulmonary disease.

Interventions

Glycopyrronium bromide was supplied in powder-filled capsules together with a single-dose dry-powder inhaler (SDDPI) device.

DRUGPlacebo to glycopyrronium bromide

Placebo to glycopyrronium bromide was supplied in powder-filled capsules together with a single-dose dry-powder inhaler (SDDPI) device.

DRUGTiotropium

Tiotropium was supplied in powder-filled capsules together with the Handihaler® device.

Sponsors

Novartis
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male or female adults aged ≥ 40 years, who have signed an Informed Consent Form prior to initiation of any study-related procedure. 2. Patients with moderate to severe stable chronic obstructive pulmonary disease (COPD, Stage II or Stage III) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines 2008. 3. Current or ex-smokers who have a smoking history of at least 10 pack years. 4. Patients with a post-bronchodilator forced expiratory volume in 1 second (FEV1) ≥ 30% and \< 80% of the predicted normal, and post-bronchodilator FEV1/forced vital capacity (FVC) \< 0.7 at Visit 2 (Day -14). 5. Patients, according to daily electronic diary data between Visit 2 (Day -14) and Visit 3 (Day 1), with a total score of 1 or more on at least 4 of the last 7 days prior to Visit 3 (Day 1).

Exclusion criteria

1. Pregnant women or nursing mothers (pregnancy confirmed by positive urine pregnancy test). 2. Women of child-bearing potential, unless using an approved method of medical or surgical contraception. 3. Patients requiring long term oxygen therapy (\> 15 h a day) on a daily basis for chronic hypoxemia, or who have been hospitalized for an exacerbation of their airways disease in the 6 weeks prior to Visit 1 (Day -21) or between Visit 1 (Day -21) and Visit 3 (Day 1). 4. Patients who have had a respiratory tract infection within 6 weeks prior to Visit 1 (Day -21). 5. Patients who, in the judgment of the investigator or the responsible Novartis personnel, have a clinically relevant laboratory abnormality or a clinically significant condition. 6. Patients with any history of asthma indicated by (but not limited to) a blood eosinophil count \> 600/mm\^3 (at Visit 1, Day -21) and onset of symptoms prior to age 40 years. 7. Patients with a history of long QT syndrome or whose QTc measured at Visit 1 (Day -21) (Fridericia method) is prolonged (\> 450 ms for males or \> 470 ms for females. Other protocol-defined inclusion/

Design outcomes

Primary

MeasureTime frameDescription
Trough Forced Expiratory Volume in 1 Second (FEV1) at Week 12Week 12FEV1 was measured with spirometry conducted according to internationally accepted standards. Trough FEV1 was defined as the average of measurements made 23 hours 15 minutes and 23 hours 45 minutes post-dose. The analysis included baseline FEV1 measurement, baseline inhaled corticosteroid use (Yes/No), FEV1 prior to inhalation of short-acting β2 agonist (SABA), and FEV1 45 min post-inhalation of SABA as covariates.

Secondary

MeasureTime frameDescription
Health-related Quality of Life (QoL) Assessed With the St. George Respiratory Questionnaire (SGRQ) at Week 52Week 52The SGRQ contained 51 patient-rated items divided into three components: Symptoms (respiratory symptoms, their frequency, and severity), Activity (activities that cause or are limited by breathlessness), and Impacts (social functioning and psychological disturbances resulting from airway disease). A total score for the 3 components was calculated and ranged from 0 to 100. Higher values indicate greater impairment of QoL. The analysis included the same covariates as the primary Outcome Measure.
Time to First Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbation During the Study (Baseline to Week 52)Baseline to Week 52 (patients with no moderate or severe exacerbations who completed the study were censored at the final visit date, which may have exceeded 52 weeks)Time to first moderate or severe COPD exacerbation was calculated as the number of days from baseline to the day on which the patient experienced the first moderate or severe COPD exacerbation. A COPD exacerbation was considered to be moderate if treatment with systemic corticosteroids and/or antibiotic was required. A COPD exacerbation was considered to be severe if treatment for moderate severity and hospitalization was required.
Change From Baseline in the Mean Daily Number of Puffs of Rescue Medication Taken During the Study (Baseline to Week 52)Baseline to Week 52The number of puffs of rescue medication taken in the previous 12 hours was recorded in the Patient Diary in the morning and evening. The mean daily number of puffs of rescue medication taken was calculated by dividing the number of puffs of rescue medication per day over the 52 weeks of the study by the number of days with non-missing rescue medication data. Rescue medication data recorded during the 14 day run-in period was used to calculate the baseline. The analysis included the same covariates as the primary Outcome Measure. A positive change score indicates more puffs taken.
Trough Forced Expiratory Volume in 1 Second (FEV1) at Day 1, Week 26, and Week 52Day 1, Week 26, and Week 52FEV1 was measured with spirometry conducted according to internationally accepted standards. Trough FEV1 was defined as the average of measurements made 23 hours 15 minutes and 23 hours 45 minutes post-dose. The analysis included the same covariates as the primary Outcome Measure.
Trough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Day 1, Week 12, Week 26, and Week 52Trough FVC is defined as the average of the post-dose 23 h 15 min and the 23 h 45 min FVC values. Just prior to FVC measurement, patients performed normal tidal breathing. The patient was given a few breaths warning before being told At the end of the next normal breath out, take a deep breath all the way in; they were then verbally encouraged to make a maximal effort before relaxing. The analysis included the same covariates as the primary Outcome Measure.
Forced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 525, 15, and 30 minutes; 1, 2, 3, 4, 6, 8, 10, and 12 hours; 23 hours 15 minutes; and 23 hours 45 minutes post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52FEV1 was measured with spirometry conducted according to internationally accepted standards. The analysis included the same covariates as the primary Outcome Measure. Data was not collected at all time points for all Days and Weeks.
Forced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 525, 15, and 30 minutes; 1, 2, 3, 4, 6, 8, 10, and 12 hours; 23 hours 15 minutes; and 23 hours 45 minutes post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Just prior to FVC measurement, patients performed normal tidal breathing. The patient was given a few breaths warning before being told At the end of the next normal breath out, take a deep breath all the way in; they were then verbally encouraged to make a maximal effort before relaxing. The analysis included the same covariates as the primary Outcome Measure. Data was not collected at all time points for all Days and Weeks.
Forced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 525, 15, and 30 minutes; and 1, 2, 3, 4 hours post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52FEV1 was measured with spirometry conducted according to internationally accepted standards. The analysis included the same covariates as the primary Outcome Measure. Data was not collected at all time points for all Days and Weeks.
Forced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 525, 15, and 30 minutes; and 1, 2, 3, 4 hours post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Just prior to FVC measurement, patients performed normal tidal breathing. The patient was given a few breaths warning before being told At the end of the next normal breath out, take a deep breath all the way in; they were then verbally encouraged to make a maximal effort before relaxing. The analysis included the same covariates as the primary Outcome Measure. Data was not collected at all time points for all Days and Weeks.
Transition Dyspnea Index (TDI) at Week 26Week 26The TDI measured changes in dyspnea from baseline during treatment and included 3 domains: Functional impairment (activities of daily living), magnitude of task (intensity of activity), and magnitude of effort (difficulty breathing). Each domain was rated from -3 to 3 (major deterioration-major improvement). The total score ranged from -9 to 9; minus scores indicate deterioration. The analysis included the same covariates as the primary Outcome Measure.
Forced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 12 Hours Post-dose at Day 1 and Weeks 12 and 52From 5 minutes to 12 hours post-dose at Day 1 and Weeks 12 and 52FEV1 was measured with spirometry conducted according to internationally accepted standards. Measurements were made at 5, 15, and 30 minutes; and 1, 2, 3, 4, 6, 8 10, and 12 hours post-dose. Standardized FEV1 AUC was calculated by the trapezoidal rule. The analysis included the same covariates as the primary Outcome Measure.
Forced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 23 Hours 45 Minutes and From 12 Hours to 23 Hours 45 Minutes Post-dose at Weeks 12 and 52From 5 minutes to 23 hours 45 minutes post-dose at Weeks 12 and 52FEV1 was measured with spirometry conducted according to internationally accepted standards. Measurements were made at 5, 15, and 30 minutes; 1, 2, 3, 4, 6, 8, 10, and 12 hours; 23 hours 15 minutes; and 23 hours 45 minutes post-dose. Standardized FEV1 AUC was calculated by the trapezoidal rule. The analysis included the same covariates as the primary Outcome Measure.
Number of Moderate or Severe Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) Per Year During the Study (Baseline to Week 52)Baseline to Week 52The number of moderate or severe exacerbations of COPD per year during the study was calculated by dividing the total number of exacerbations during the study by the total number of years of treatment. A COPD exacerbation was considered to be moderate if treatment with systemic corticosteroids and/or antibiotic was required. A COPD exacerbation was considered to be severe if treatment for moderate severity and hospitalization was required.
Percentage of Patients Who Experienced a Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbation During the Study (Baseline to Week 52)Baseline to Week 52A COPD exacerbation was considered to be moderate if treatment with systemic corticosteroids and/or antibiotic was required. A COPD exacerbation was considered to be severe if treatment for moderate severity and hospitalization was required.
Percentage of Nights With no Nighttime Awakenings During the Study (Baseline to Week 52)Baseline to Week 52A night with no nighttime awakenings was defined as any night where the patient did not wake up due to 1 or more of 6 symptoms (respiratory symptoms, cough, wheeze, amount of sputum, color of sputum, and breathlessness). Symptoms occurring during the previous 12 hours were recorded each morning and evening by the patient in an electronic diary. The percentage of nights with 'no nighttime awakenings' was calculated as the total number of nights with no nighttime awakenings over the 52 week treatment period divided by the total number of nights where diary recordings were made.
Percentage of Days With no Daytime Symptoms During the Study (Baseline to Week 52)Baseline to Week 52A day with no daytime symptoms was defined as any day where the patient recorded no cough, no wheeze, no production of sputum, no feeling of breathlessness (other than when running), and no puffs of rescue medication during the previous 12 hours in evening entry in the electronic patient diary. The percentage of days with no daytime symptoms was calculated as the total number of days with no daytime symptoms over the 52 week treatment period divided by the total number of days where diary recordings were made.
Percentage of Days Able to Perform Usual Daily Activities During the Study (Baseline to Week 52)Baseline to Week 52A day able to perform usual daily activities was defined as any day where the patient recorded in their electronic diary in the evening that they were not prevented from performing their usual daily activities due to respiratory symptoms during the previous 12 hours. The percentage of days able to perform usual daily activities was calculated as the total number of days able to perform usual daily activities over the 52 week treatment period divided by the total number of days where diary recordings were made.
Change From Baseline in the Mean Daily Total Symptom Score During the Study (Baseline to Week 52)Baseline to Week 52The daily total symptom score was defined as the sum of the morning and evening patient self-reported diary assessments of 6 symptoms (respiratory symptoms/impact on daily activities, cough, wheeze, amount of sputum, color of sputum, and breathlessness). Means for baseline (14 day maximum run-in period) and the 52 week treatment period were calculated. Mean scores ranged from 0-18, with a higher score indicating worse symptoms. A negative change score indicated improvement.
Forced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52From 5 minutes to 4 hours post-dose at Day 1 and Weeks 12, 26, and 52FEV1 was measured with spirometry conducted according to internationally accepted standards. Measurements were made at 5, 15, and 30 minutes; and 1, 2, 3, and 4 hours post-dose. Standardized FEV1 AUC was calculated by the trapezoidal rule. The analysis included the same covariates as the primary Outcome Measure.

Countries

Argentina, Canada, Chile, France, Germany, Hungary, Israel, Italy, Mexico, Netherlands, New Zealand, Peru, Poland, Russia, South Korea, United States

Participant flow

Recruitment details

A total of 1993 patients were screened from 180 participating sites, of whom 1066 were randomized to 1 of the 3 treatment groups in a 2:1:1 ratio glycopyrronium bromide:placebo:tiotropium.

Participants by arm

ArmCount
Glycopyrronium Bromide 50 μg
Patients inhaled glycopyrronium bromide 50 μg once daily in the morning between 8:00 AM and 10:00 AM via a single-dose dry-powder inhaler (SDDPI) for 52 weeks. Daily inhaled corticosteroid treatment (if applicable) was to remain stable throughout the study. The short-acting β2-agonist salbutamol/albuterol was available for rescue use throughout the study.
525
Placebo to Glycopyrronium Bromide
Patients inhaled placebo to glycopyrronium bromide once daily in the morning between 8:00 AM and 10:00 AM via a single-dose dry-powder inhaler (SDDPI) for 52 weeks. Daily inhaled corticosteroid treatment (if applicable) was to remain stable throughout the study. The short-acting β2-agonist salbutamol/albuterol was available for rescue use throughout the study.
268
Tiotropium 18 μg
Patients inhaled tiotropium 18 μg once daily in the morning between 8:00 AM and 10:00 AM via a single-dose dry-powder inhaler (SDDPI) for 52 weeks. Daily inhaled corticosteroid treatment (if applicable) was to remain stable throughout the study. The short-acting β2-agonist salbutamol/albuterol was available for rescue use throughout the study.
267
Total1,060

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyAbnormal laboratory value(s)010
Overall StudyAbnormal test procedure result(s)011
Overall StudyAdministrative problems412
Overall StudyAdverse Event402918
Overall StudyDeath222
Overall StudyLost to Follow-up773
Overall StudyPatient inability to use the device010
Overall StudyProtocol deviation524
Overall StudySubject withdrew consent402326
Overall StudyUnsatisfactory therapeutic effect2096

Baseline characteristics

CharacteristicGlycopyrronium Bromide 50 μgPlacebo to Glycopyrronium BromideTiotropium 18 μgTotal
Age Continuous63.5 years
STANDARD_DEVIATION 9.05
63.6 years
STANDARD_DEVIATION 9.14
63.9 years
STANDARD_DEVIATION 8.25
63.6 years
STANDARD_DEVIATION 8.87
Sex: Female, Male
Female
186 Participants95 Participants99 Participants380 Participants
Sex: Female, Male
Male
339 Participants173 Participants168 Participants680 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
305 / 525164 / 268156 / 267
serious
Total, serious adverse events
65 / 52543 / 26840 / 267

Outcome results

Primary

Trough Forced Expiratory Volume in 1 Second (FEV1) at Week 12

FEV1 was measured with spirometry conducted according to internationally accepted standards. Trough FEV1 was defined as the average of measurements made 23 hours 15 minutes and 23 hours 45 minutes post-dose. The analysis included baseline FEV1 measurement, baseline inhaled corticosteroid use (Yes/No), FEV1 prior to inhalation of short-acting β2 agonist (SABA), and FEV1 45 min post-inhalation of SABA as covariates.

Time frame: Week 12

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgTrough Forced Expiratory Volume in 1 Second (FEV1) at Week 121.469 LitersStandard Error 0.0141
Placebo to Glycopyrronium BromideTrough Forced Expiratory Volume in 1 Second (FEV1) at Week 121.372 LitersStandard Error 0.0173
Tiotropium 18 μgTrough Forced Expiratory Volume in 1 Second (FEV1) at Week 121.455 LitersStandard Error 0.017
Secondary

Change From Baseline in the Mean Daily Number of Puffs of Rescue Medication Taken During the Study (Baseline to Week 52)

The number of puffs of rescue medication taken in the previous 12 hours was recorded in the Patient Diary in the morning and evening. The mean daily number of puffs of rescue medication taken was calculated by dividing the number of puffs of rescue medication per day over the 52 weeks of the study by the number of days with non-missing rescue medication data. Rescue medication data recorded during the 14 day run-in period was used to calculate the baseline. The analysis included the same covariates as the primary Outcome Measure. A positive change score indicates more puffs taken.

Time frame: Baseline to Week 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgChange From Baseline in the Mean Daily Number of Puffs of Rescue Medication Taken During the Study (Baseline to Week 52)-1.58 PuffsStandard Error 0.151
Placebo to Glycopyrronium BromideChange From Baseline in the Mean Daily Number of Puffs of Rescue Medication Taken During the Study (Baseline to Week 52)-1.20 PuffsStandard Error 0.184
Tiotropium 18 μgChange From Baseline in the Mean Daily Number of Puffs of Rescue Medication Taken During the Study (Baseline to Week 52)-1.83 PuffsStandard Error 0.183
Secondary

Change From Baseline in the Mean Daily Total Symptom Score During the Study (Baseline to Week 52)

The daily total symptom score was defined as the sum of the morning and evening patient self-reported diary assessments of 6 symptoms (respiratory symptoms/impact on daily activities, cough, wheeze, amount of sputum, color of sputum, and breathlessness). Means for baseline (14 day maximum run-in period) and the 52 week treatment period were calculated. Mean scores ranged from 0-18, with a higher score indicating worse symptoms. A negative change score indicated improvement.

Time frame: Baseline to Week 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgChange From Baseline in the Mean Daily Total Symptom Score During the Study (Baseline to Week 52)-1.85 Units on a scaleStandard Error 0.125
Placebo to Glycopyrronium BromideChange From Baseline in the Mean Daily Total Symptom Score During the Study (Baseline to Week 52)-1.42 Units on a scaleStandard Error 0.149
Tiotropium 18 μgChange From Baseline in the Mean Daily Total Symptom Score During the Study (Baseline to Week 52)-1.87 Units on a scaleStandard Error 0.149
Secondary

Forced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52

FEV1 was measured with spirometry conducted according to internationally accepted standards. The analysis included the same covariates as the primary Outcome Measure. Data was not collected at all time points for all Days and Weeks.

Time frame: 5, 15, and 30 minutes; 1, 2, 3, 4, 6, 8, 10, and 12 hours; 23 hours 15 minutes; and 23 hours 45 minutes post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52

Population: Full Analysis Set (FAS), serial spirometry subgroup: A subgroup of approximately one third of all randomized patients who received at least 1 dose of study medication.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 12 (n=130, 69, 70)1.522 LitersStandard Error 0.0254
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=123, 61, 58)1.537 LitersStandard Error 0.0332
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=124, 64, 68)1.584 LitersStandard Error 0.0319
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=144, 75, 75)1.639 LitersStandard Error 0.0202
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=123, 61, 58)1.520 LitersStandard Error 0.0305
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 6 (n=123, 63, 69)1.558 LitersStandard Error 0.0321
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=126, 66, 67)1.518 LitersStandard Error 0.0269
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 8 (n=121, 64, 69)1.535 LitersStandard Error 0.031
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=119, 61, 58)1.512 LitersStandard Error 0.0305
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 10 (n=124, 61, 69)1.541 LitersStandard Error 0.0296
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=129, 71, 72)1.471 LitersStandard Error 0.0214
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=125, 62, 63)1.557 LitersStandard Error 0.0285
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 12 (n=122, 58, 68)1.522 LitersStandard Error 0.0313
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=125, 62, 62)1.567 LitersStandard Error 0.0302
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=123, 62, 63)1.529 LitersStandard Error 0.03
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 22 (n=117, 60, 63)1.420 LitersStandard Error 0.0268
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 16 (n=117, 53, 46)1.377 LitersStandard Error 0.0309
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=125, 62, 63)1.515 LitersStandard Error 0.0293
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 16 (n=109, 56, 57)1.431 LitersStandard Error 0.032
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=117, 56, 61)1.483 LitersStandard Error 0.0296
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=124, 65, 63)1.513 LitersStandard Error 0.0294
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=128, 74, 75)1.518 LitersStandard Error 0.021
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=120, 55, 61)1.477 LitersStandard Error 0.0323
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=123, 65, 64)1.538 LitersStandard Error 0.0296
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=124, 65, 65)1.557 LitersStandard Error 0.0309
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 15 minutes (n=121, 62, 57)1.447 LitersStandard Error 0.0287
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=124, 64, 62)1.577 LitersStandard Error 0.0304
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=125, 65, 65)1.570 LitersStandard Error 0.0303
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=129, 67, 66)1.523 LitersStandard Error 0.0251
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=124, 64, 64)1.614 LitersStandard Error 0.0303
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=125, 66, 63)1.518 LitersStandard Error 0.0281
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=135, 65, 73)1.494 LitersStandard Error 0.0246
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=124, 64, 63)1.590 LitersStandard Error 0.0317
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=124, 65, 63)1.535 LitersStandard Error 0.0285
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=127, 64, 64)1.546 LitersStandard Error 0.0275
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=125, 65, 63)1.576 LitersStandard Error 0.0277
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=143, 74, 73)1.629 LitersStandard Error 0.0199
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=125, 64, 64)1.529 LitersStandard Error 0.0285
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (n=123, 62, 64)1.483 LitersStandard Error 0.0278
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=139, 75, 74)1.548 LitersStandard Error 0.0152
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=121, 61, 61)1.521 LitersStandard Error 0.028
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=136, 67, 70)1.575 LitersStandard Error 0.0239
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 10 (n=119, 59, 55)1.478 LitersStandard Error 0.0304
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n= 139, 70, 74)1.551 LitersStandard Error 0.0236
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=140, 68, 74)1.575 LitersStandard Error 0.0242
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=144, 70, 74)1.599 LitersStandard Error 0.0221
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=133, 70, 72)1.530 LitersStandard Error 0.0246
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=134, 66, 68)1.550 LitersStandard Error 0.0247
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 12 (n=120, 58, 52)1.451 LitersStandard Error 0.0334
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=121, 60, 55)1.535 LitersStandard Error 0.0297
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=143, 77, 74)1.561 LitersStandard Error 0.018
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=135, 67, 70)1.630 LitersStandard Error 0.026
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 6 (n=142, 71, 74)1.578 LitersStandard Error 0.0204
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 8 (n=119, 59, 54)1.473 LitersStandard Error 0.03
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=128, 66, 70)1.562 LitersStandard Error 0.0268
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=144, 76, 75)1.583 LitersStandard Error 0.0172
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 6 (n=118, 59, 54)1.494 LitersStandard Error 0.0294
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=130, 66, 71)1.583 LitersStandard Error 0.0267
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=122, 59, 58)1.502 LitersStandard Error 0.0282
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=123, 62, 56)1.558 LitersStandard Error 0.0263
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=130, 67, 71)1.603 LitersStandard Error 0.0265
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 8 (n=137, 70, 75)1.544 LitersStandard Error 0.0226
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=124, 61, 58)1.554 LitersStandard Error 0.0295
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=130, 69, 70)1.497 LitersStandard Error 0.0254
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 22 (n=118, 60, 52)1.391 LitersStandard Error 0.0302
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=135, 74, 74)1.494 LitersStandard Error 0.0135
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=124, 60, 57)1.456 LitersStandard Error 0.0276
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=125, 62, 57)1.525 LitersStandard Error 0.0271
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=133, 69, 67)1.517 LitersStandard Error 0.0275
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day1, hour 10 (n=134, 72, 75)1.546 LitersStandard Error 0.0235
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=125, 62, 58)1.483 LitersStandard Error 0.028
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=132, 67, 69)1.557 LitersStandard Error 0.0273
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 45 minutes (n=122, 61, 57)1.434 LitersStandard Error 0.0281
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=123, 60, 58)1.545 LitersStandard Error 0.0287
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=129, 65, 68)1.596 LitersStandard Error 0.029
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=120, 60, 57)1.490 LitersStandard Error 0.0269
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=123, 60, 57)1.529 LitersStandard Error 0.0285
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=126, 64, 69)1.600 LitersStandard Error 0.0291
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=125, 62, 57)1.356 LitersStandard Error 0.0359
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=135, 74, 74)1.416 LitersStandard Error 0.0166
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=139, 75, 74)1.428 LitersStandard Error 0.0185
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=143, 77, 74)1.409 LitersStandard Error 0.0218
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=144, 76, 75)1.404 LitersStandard Error 0.0213
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=144, 75, 75)1.445 LitersStandard Error 0.0248
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=143, 74, 73)1.435 LitersStandard Error 0.0249
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=144, 70, 74)1.415 LitersStandard Error 0.0281
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 6 (n=142, 71, 74)1.426 LitersStandard Error 0.0255
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 8 (n=137, 70, 75)1.431 LitersStandard Error 0.0284
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day1, hour 10 (n=134, 72, 75)1.415 LitersStandard Error 0.029
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 12 (n=130, 69, 70)1.369 LitersStandard Error 0.0307
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=129, 71, 72)1.396 LitersStandard Error 0.0259
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=128, 74, 75)1.446 LitersStandard Error 0.0252
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=135, 65, 73)1.421 LitersStandard Error 0.0315
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=133, 70, 72)1.411 LitersStandard Error 0.0307
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n= 139, 70, 74)1.417 LitersStandard Error 0.0297
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=140, 68, 74)1.409 LitersStandard Error 0.0305
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=134, 66, 68)1.448 LitersStandard Error 0.0319
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=136, 67, 70)1.452 LitersStandard Error 0.0305
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=135, 67, 70)1.481 LitersStandard Error 0.0327
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=128, 66, 70)1.417 LitersStandard Error 0.0341
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=130, 66, 71)1.441 LitersStandard Error 0.034
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=130, 67, 71)1.427 LitersStandard Error 0.0335
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=130, 69, 70)1.385 LitersStandard Error 0.0319
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=129, 67, 66)1.373 LitersStandard Error 0.0317
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=133, 69, 67)1.362 LitersStandard Error 0.0336
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=132, 67, 69)1.369 LitersStandard Error 0.0341
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=129, 65, 68)1.434 LitersStandard Error 0.0365
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=126, 64, 69)1.443 LitersStandard Error 0.0375
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=124, 64, 68)1.442 LitersStandard Error 0.0407
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 6 (n=123, 63, 69)1.443 LitersStandard Error 0.0407
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 10 (n=124, 61, 69)1.435 LitersStandard Error 0.0392
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 22 (n=117, 60, 63)1.349 LitersStandard Error 0.035
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=126, 66, 67)1.456 LitersStandard Error 0.0345
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=124, 65, 63)1.470 LitersStandard Error 0.0377
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=124, 65, 65)1.422 LitersStandard Error 0.038
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=125, 65, 65)1.409 LitersStandard Error 0.037
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=125, 66, 63)1.393 LitersStandard Error 0.0348
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=125, 65, 63)1.391 LitersStandard Error 0.0349
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (n=123, 62, 64)1.361 LitersStandard Error 0.0368
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=121, 61, 61)1.377 LitersStandard Error 0.0373
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=127, 64, 64)1.364 LitersStandard Error 0.0359
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=124, 64, 63)1.422 LitersStandard Error 0.0403
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=124, 64, 64)1.442 LitersStandard Error 0.0391
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=124, 64, 62)1.416 LitersStandard Error 0.0384
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=120, 55, 61)1.374 LitersStandard Error 0.0422
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=117, 56, 61)1.401 LitersStandard Error 0.0395
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=125, 62, 63)1.359 LitersStandard Error 0.0385
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=123, 62, 63)1.360 LitersStandard Error 0.0394
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=125, 62, 62)1.353 LitersStandard Error 0.0398
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=125, 62, 63)1.352 LitersStandard Error 0.0376
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=123, 61, 58)1.391 LitersStandard Error 0.0431
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=120, 60, 57)1.357 LitersStandard Error 0.0348
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=123, 60, 57)1.375 LitersStandard Error 0.0369
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=123, 60, 58)1.368 LitersStandard Error 0.0375
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=125, 62, 58)1.366 LitersStandard Error 0.037
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=124, 61, 58)1.418 LitersStandard Error 0.0393
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=121, 60, 55)1.381 LitersStandard Error 0.0395
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 6 (n=118, 59, 54)1.370 LitersStandard Error 0.0392
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 8 (n=119, 59, 54)1.358 LitersStandard Error 0.0398
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 8 (n=121, 64, 69)1.408 LitersStandard Error 0.0385
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 12 (n=122, 58, 68)1.422 LitersStandard Error 0.0417
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 16 (n=109, 56, 57)1.360 LitersStandard Error 0.0425
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=123, 65, 64)1.430 LitersStandard Error 0.0362
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=124, 65, 63)1.380 LitersStandard Error 0.0354
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=125, 64, 64)1.353 LitersStandard Error 0.0372
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=119, 61, 58)1.394 LitersStandard Error 0.0401
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=123, 61, 58)1.412 LitersStandard Error 0.0403
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=124, 60, 57)1.337 LitersStandard Error 0.0368
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=122, 59, 58)1.380 LitersStandard Error 0.0378
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=123, 62, 56)1.384 LitersStandard Error 0.0349
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 10 (n=119, 59, 55)1.349 LitersStandard Error 0.0397
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 15 minutes (n=121, 62, 57)1.362 LitersStandard Error 0.0378
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 45 minutes (n=122, 61, 57)1.337 LitersStandard Error 0.0372
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 12 (n=120, 58, 52)1.369 LitersStandard Error 0.0446
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 16 (n=117, 53, 46)1.277 LitersStandard Error 0.0422
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 22 (n=118, 60, 52)1.314 LitersStandard Error 0.0397
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=124, 64, 68)1.535 LitersStandard Error 0.0383
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=123, 61, 58)1.491 LitersStandard Error 0.0396
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=126, 64, 69)1.566 LitersStandard Error 0.0353
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 45 minutes (n=122, 61, 57)1.359 LitersStandard Error 0.0364
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=123, 61, 58)1.517 LitersStandard Error 0.0424
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 6 (n=142, 71, 74)1.575 LitersStandard Error 0.0252
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=120, 60, 57)1.422 LitersStandard Error 0.0341
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=129, 65, 68)1.565 LitersStandard Error 0.0353
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 12 (n=120, 58, 52)1.347 LitersStandard Error 0.0444
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=123, 60, 57)1.452 LitersStandard Error 0.0362
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=132, 67, 69)1.519 LitersStandard Error 0.0333
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=124, 61, 58)1.479 LitersStandard Error 0.0382
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=123, 60, 58)1.470 LitersStandard Error 0.0366
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=124, 60, 57)1.377 LitersStandard Error 0.0359
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=122, 59, 58)1.428 LitersStandard Error 0.0364
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=133, 69, 67)1.488 LitersStandard Error 0.0335
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=139, 75, 74)1.485 LitersStandard Error 0.0185
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=125, 62, 58)1.407 LitersStandard Error 0.0362
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=129, 67, 66)1.481 LitersStandard Error 0.0315
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=130, 69, 70)1.474 LitersStandard Error 0.0315
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=125, 62, 57)1.439 LitersStandard Error 0.0352
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=130, 67, 71)1.549 LitersStandard Error 0.0323
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=123, 62, 56)1.487 LitersStandard Error 0.0345
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=130, 66, 71)1.534 LitersStandard Error 0.0326
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=144, 70, 74)1.560 LitersStandard Error 0.0275
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=121, 60, 55)1.468 LitersStandard Error 0.039
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=128, 66, 70)1.520 LitersStandard Error 0.0326
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 6 (n=118, 59, 54)1.461 LitersStandard Error 0.0388
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=135, 67, 70)1.584 LitersStandard Error 0.0317
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 8 (n=119, 59, 54)1.418 LitersStandard Error 0.0394
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 10 (n=119, 59, 55)1.419 LitersStandard Error 0.0391
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=136, 67, 70)1.543 LitersStandard Error 0.0295
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=135, 65, 73)1.490 LitersStandard Error 0.0299
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=140, 68, 74)1.540 LitersStandard Error 0.0296
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n= 139, 70, 74)1.516 LitersStandard Error 0.0289
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=134, 66, 68)1.525 LitersStandard Error 0.0305
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=133, 70, 72)1.537 LitersStandard Error 0.0303
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=128, 74, 75)1.499 LitersStandard Error 0.0249
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 6 (n=123, 63, 69)1.520 LitersStandard Error 0.0381
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=143, 74, 73)1.587 LitersStandard Error 0.0248
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 15 minutes (n=121, 62, 57)1.387 LitersStandard Error 0.0371
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (n=123, 62, 64)1.415 LitersStandard Error 0.0352
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=129, 71, 72)1.481 LitersStandard Error 0.0255
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=121, 61, 61)1.464 LitersStandard Error 0.0358
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=125, 65, 63)1.502 LitersStandard Error 0.035
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=125, 64, 64)1.439 LitersStandard Error 0.0359
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=124, 65, 63)1.479 LitersStandard Error 0.0356
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 22 (n=118, 60, 52)1.282 LitersStandard Error 0.0396
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=127, 64, 64)1.462 LitersStandard Error 0.0349
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=125, 66, 63)1.453 LitersStandard Error 0.0351
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 12 (n=130, 69, 70)1.480 LitersStandard Error 0.0306
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=124, 64, 63)1.520 LitersStandard Error 0.0395
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=125, 65, 65)1.535 LitersStandard Error 0.0368
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=144, 75, 75)1.569 LitersStandard Error 0.0247
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=124, 64, 64)1.555 LitersStandard Error 0.038
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=124, 65, 65)1.530 LitersStandard Error 0.0377
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=123, 65, 64)1.515 LitersStandard Error 0.0359
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=124, 64, 62)1.519 LitersStandard Error 0.0377
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=124, 65, 63)1.488 LitersStandard Error 0.0374
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 16 (n=117, 53, 46)1.329 LitersStandard Error 0.042
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=120, 55, 61)1.416 LitersStandard Error 0.0399
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=126, 66, 67)1.520 LitersStandard Error 0.0335
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=144, 76, 75)1.514 LitersStandard Error 0.0212
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=117, 56, 61)1.405 LitersStandard Error 0.0376
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 22 (n=117, 60, 63)1.371 LitersStandard Error 0.0333
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=135, 74, 74)1.447 LitersStandard Error 0.0164
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=125, 62, 63)1.407 LitersStandard Error 0.0372
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 16 (n=109, 56, 57)1.378 LitersStandard Error 0.0404
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=143, 77, 74)1.483 LitersStandard Error 0.0219
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=123, 62, 63)1.425 LitersStandard Error 0.0379
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 12 (n=122, 58, 68)1.487 LitersStandard Error 0.0382
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day1, hour 10 (n=134, 72, 75)1.537 LitersStandard Error 0.0286
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=125, 62, 62)1.452 LitersStandard Error 0.0385
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 10 (n=124, 61, 69)1.532 LitersStandard Error 0.0365
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 8 (n=137, 70, 75)1.545 LitersStandard Error 0.0278
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=125, 62, 63)1.472 LitersStandard Error 0.0361
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 8 (n=121, 64, 69)1.479 LitersStandard Error 0.0374
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=119, 61, 58)1.490 LitersStandard Error 0.0394
Secondary

Forced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52

FEV1 was measured with spirometry conducted according to internationally accepted standards. The analysis included the same covariates as the primary Outcome Measure. Data was not collected at all time points for all Days and Weeks.

Time frame: 5, 15, and 30 minutes; and 1, 2, 3, 4 hours post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=400, 186, 199)1.525 LitersStandard Error 0.0171
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=430, 207, 220)1.525 LitersStandard Error 0.0164
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=433, 209, 220)1.546 LitersStandard Error 0.016
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=402, 186, 202)1.526 LitersStandard Error 0.0177
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=431, 207, 221)1.544 LitersStandard Error 0.0164
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=479, 222, 234)1.538 LitersStandard Error 0.0126
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=404, 190, 201)1.499 LitersStandard Error 0.0161
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (421, 202, 213)1.479 LitersStandard Error 0.0153
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=402, 189, 202)1.471 LitersStandard Error 0.0164
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=394, 183, 200)1.471 LitersStandard Error 0.0159
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=414, 200, 207)1.504 LitersStandard Error 0.0155
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=511, 256, 254)1.552 LitersStandard Error 0.0082
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=392, 186, 204)1.504 LitersStandard Error 0.0166
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=391, 187, 203)1.496 LitersStandard Error 0.0156
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=425, 206, 212)1.541 LitersStandard Error 0.016
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=428, 209, 219)1.530 LitersStandard Error 0.0155
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=386, 185, 199)1.454 LitersStandard Error 0.0155
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=420, 203, 208)1.570 LitersStandard Error 0.0176
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=480, 223, 234)1.564 LitersStandard Error 0.0129
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=416, 204, 213)1.570 LitersStandard Error 0.0181
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=498, 223, 243)1.491 LitersStandard Error 0.0123
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=405, 189, 201)1.518 LitersStandard Error 0.0183
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=416, 203, 208)1.547 LitersStandard Error 0.0175
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=453, 212, 230)1.502 LitersStandard Error 0.0136
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=454, 217, 227)1.529 LitersStandard Error 0.0126
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=405, 188, 201)1.511 LitersStandard Error 0.0171
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=401, 185, 198)1.474 LitersStandard Error 0.0175
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=502, 255, 254)1.501 LitersStandard Error 0.0074
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=398, 189, 199)1.489 LitersStandard Error 0.0172
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=407, 191, 214)1.508 LitersStandard Error 0.0172
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=459, 220, 225)1.550 LitersStandard Error 0.0132
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=410, 196, 215)1.518 LitersStandard Error 0.0172
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=487, 229, 239)1.527 LitersStandard Error 0.0123
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=460, 220, 226)1.569 LitersStandard Error 0.0125
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=401, 188, 197)1.436 LitersStandard Error 0.0155
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=481, 243, 239)1.459 LitersStandard Error 0.0093
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=448, 205, 222)1.527 LitersStandard Error 0.0131
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=408, 194, 212)1.481 LitersStandard Error 0.0167
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=504, 239, 250)1.590 LitersStandard Error 0.0095
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=455, 212, 226)1.522 LitersStandard Error 0.0139
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n=503, 233, 242)1.538 LitersStandard Error 0.0122
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=510, 248, 252)1.590 LitersStandard Error 0.0088
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=455, 210, 227)1.556 LitersStandard Error 0.0139
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=513, 253, 252)1.612 LitersStandard Error 0.009
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=507, 252, 254)1.524 LitersStandard Error 0.0103
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=446, 207, 225)1.595 LitersStandard Error 0.0145
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=405, 187, 202)1.464 LitersStandard Error 0.0175
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=495, 255, 253)1.443 LitersStandard Error 0.0067
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=444, 204, 225)1.592 LitersStandard Error 0.0145
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=437, 202, 224)1.558 LitersStandard Error 0.0152
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=501, 229, 240)1.561 LitersStandard Error 0.0121
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 45 (n=395, 185, 199)1.424 LitersStandard Error 0.0165
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=430, 200, 214)1.481 LitersStandard Error 0.0143
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=412, 195, 215)1.534 LitersStandard Error 0.0171
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 15 (n=388, 183, 198)1.419 LitersStandard Error 0.0169
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=426, 195, 205)1.493 LitersStandard Error 0.0149
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=429, 207, 218)1.514 LitersStandard Error 0.0151
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=424, 206, 213)1.513 LitersStandard Error 0.0161
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=476, 221, 231)1.509 LitersStandard Error 0.0125
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=397, 184, 199)1.504 LitersStandard Error 0.0176
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=430, 206, 218)1.495 LitersStandard Error 0.0159
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=474, 239, 232)1.482 LitersStandard Error 0.0094
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (421, 202, 213)1.339 LitersStandard Error 0.0189
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=502, 255, 254)1.359 LitersStandard Error 0.009
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=511, 256, 254)1.353 LitersStandard Error 0.0101
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=474, 239, 232)1.390 LitersStandard Error 0.0117
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=498, 223, 243)1.368 LitersStandard Error 0.0157
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=487, 229, 239)1.371 LitersStandard Error 0.0154
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n=503, 233, 242)1.368 LitersStandard Error 0.0152
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=501, 229, 240)1.379 LitersStandard Error 0.0153
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=476, 221, 231)1.371 LitersStandard Error 0.0161
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=479, 222, 234)1.389 LitersStandard Error 0.0162
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=480, 223, 234)1.396 LitersStandard Error 0.0165
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=454, 217, 227)1.366 LitersStandard Error 0.0159
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=453, 212, 230)1.349 LitersStandard Error 0.0173
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=448, 205, 222)1.352 LitersStandard Error 0.0171
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=455, 212, 226)1.352 LitersStandard Error 0.0176
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=455, 210, 227)1.364 LitersStandard Error 0.0178
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=446, 207, 225)1.423 LitersStandard Error 0.0185
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=437, 202, 224)1.416 LitersStandard Error 0.0193
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=430, 200, 214)1.381 LitersStandard Error 0.0183
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=429, 207, 218)1.373 LitersStandard Error 0.0185
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=433, 209, 220)1.372 LitersStandard Error 0.0194
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=430, 206, 218)1.351 LitersStandard Error 0.0198
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=430, 207, 220)1.362 LitersStandard Error 0.0203
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=431, 207, 221)1.362 LitersStandard Error 0.0203
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=414, 200, 207)1.340 LitersStandard Error 0.0193
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=425, 206, 212)1.345 LitersStandard Error 0.0193
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=420, 203, 208)1.388 LitersStandard Error 0.0212
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=416, 204, 213)1.398 LitersStandard Error 0.0216
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=416, 203, 208)1.384 LitersStandard Error 0.0211
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=405, 187, 202)1.326 LitersStandard Error 0.0217
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=401, 185, 198)1.354 LitersStandard Error 0.0218
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=407, 191, 214)1.333 LitersStandard Error 0.0215
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=398, 189, 199)1.342 LitersStandard Error 0.0218
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=405, 188, 201)1.344 LitersStandard Error 0.0218
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=405, 189, 201)1.350 LitersStandard Error 0.0229
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=386, 185, 199)1.336 LitersStandard Error 0.0197
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=391, 187, 203)1.341 LitersStandard Error 0.0199
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=392, 186, 204)1.341 LitersStandard Error 0.021
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=401, 188, 197)1.305 LitersStandard Error 0.02
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=394, 183, 200)1.323 LitersStandard Error 0.0208
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=402, 189, 202)1.319 LitersStandard Error 0.0209
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=404, 190, 201)1.325 LitersStandard Error 0.0205
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=402, 186, 202)1.363 LitersStandard Error 0.0224
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=400, 186, 199)1.344 LitersStandard Error 0.0215
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=397, 184, 199)1.346 LitersStandard Error 0.0222
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 15 (n=388, 183, 198)1.303 LitersStandard Error 0.0215
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 45 (n=395, 185, 199)1.320 LitersStandard Error 0.021
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=495, 255, 253)1.357 LitersStandard Error 0.0081
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=507, 252, 254)1.357 LitersStandard Error 0.0126
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=513, 253, 252)1.397 LitersStandard Error 0.0113
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=510, 248, 252)1.389 LitersStandard Error 0.0111
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=504, 239, 250)1.396 LitersStandard Error 0.0121
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=481, 243, 239)1.364 LitersStandard Error 0.0115
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=459, 220, 225)1.376 LitersStandard Error 0.0164
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=460, 220, 226)1.378 LitersStandard Error 0.0158
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=444, 204, 225)1.414 LitersStandard Error 0.0186
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=426, 195, 205)1.413 LitersStandard Error 0.019
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=428, 209, 219)1.372 LitersStandard Error 0.0189
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=424, 206, 213)1.341 LitersStandard Error 0.0196
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=408, 194, 212)1.338 LitersStandard Error 0.021
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=410, 196, 215)1.331 LitersStandard Error 0.0214
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=412, 195, 215)1.331 LitersStandard Error 0.0213
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=404, 190, 201)1.482 LitersStandard Error 0.0198
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=430, 207, 220)1.495 LitersStandard Error 0.0196
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=426, 195, 205)1.472 LitersStandard Error 0.0187
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=402, 186, 202)1.511 LitersStandard Error 0.0214
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=430, 206, 218)1.464 LitersStandard Error 0.0192
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=429, 207, 218)1.487 LitersStandard Error 0.0181
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=400, 186, 199)1.509 LitersStandard Error 0.0207
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=433, 209, 220)1.505 LitersStandard Error 0.019
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=479, 222, 234)1.508 LitersStandard Error 0.0157
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=397, 184, 199)1.501 LitersStandard Error 0.0213
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=430, 200, 214)1.457 LitersStandard Error 0.0177
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=410, 196, 215)1.444 LitersStandard Error 0.0206
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=437, 202, 224)1.534 LitersStandard Error 0.0183
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=428, 209, 219)1.491 LitersStandard Error 0.0186
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 45 (n=395, 185, 199)1.411 LitersStandard Error 0.0201
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=446, 207, 225)1.558 LitersStandard Error 0.0178
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=476, 221, 231)1.488 LitersStandard Error 0.0157
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=502, 255, 254)1.437 LitersStandard Error 0.009
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=455, 210, 227)1.528 LitersStandard Error 0.0171
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=501, 229, 240)1.525 LitersStandard Error 0.015
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=507, 252, 254)1.468 LitersStandard Error 0.0125
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=481, 243, 239)1.457 LitersStandard Error 0.0115
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=513, 253, 252)1.549 LitersStandard Error 0.0112
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=455, 212, 226)1.491 LitersStandard Error 0.017
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=420, 203, 208)1.524 LitersStandard Error 0.021
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=510, 248, 252)1.560 LitersStandard Error 0.0109
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=448, 205, 222)1.501 LitersStandard Error 0.0166
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=416, 203, 208)1.504 LitersStandard Error 0.0208
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=504, 239, 250)1.549 LitersStandard Error 0.0117
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=453, 212, 230)1.477 LitersStandard Error 0.0167
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n=503, 233, 242)1.504 LitersStandard Error 0.015
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=474, 239, 232)1.473 LitersStandard Error 0.0118
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=407, 191, 214)1.443 LitersStandard Error 0.0206
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=412, 195, 215)1.464 LitersStandard Error 0.0205
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=408, 194, 212)1.422 LitersStandard Error 0.0202
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=498, 223, 243)1.472 LitersStandard Error 0.0151
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=398, 189, 199)1.459 LitersStandard Error 0.0213
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=405, 187, 202)1.415 LitersStandard Error 0.0212
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=459, 220, 225)1.515 LitersStandard Error 0.0163
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=405, 188, 201)1.477 LitersStandard Error 0.0211
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=416, 204, 213)1.526 LitersStandard Error 0.0211
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=454, 217, 227)1.499 LitersStandard Error 0.0157
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=405, 189, 201)1.496 LitersStandard Error 0.0222
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=425, 206, 212)1.487 LitersStandard Error 0.019
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=401, 185, 198)1.426 LitersStandard Error 0.0215
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=386, 185, 199)1.429 LitersStandard Error 0.019
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=424, 206, 213)1.451 LitersStandard Error 0.0193
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=487, 229, 239)1.514 LitersStandard Error 0.0151
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=391, 187, 203)1.462 LitersStandard Error 0.0192
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=414, 200, 207)1.458 LitersStandard Error 0.0191
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=460, 220, 226)1.531 LitersStandard Error 0.0157
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=392, 186, 204)1.475 LitersStandard Error 0.02
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=480, 223, 234)1.525 LitersStandard Error 0.016
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=401, 188, 197)1.419 LitersStandard Error 0.0195
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (421, 202, 213)1.429 LitersStandard Error 0.0185
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 15 (n=388, 183, 198)1.397 LitersStandard Error 0.0205
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=394, 183, 200)1.451 LitersStandard Error 0.0198
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=495, 255, 253)1.402 LitersStandard Error 0.0081
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=444, 204, 225)1.561 LitersStandard Error 0.0177
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=402, 189, 202)1.451 LitersStandard Error 0.0202
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=431, 207, 221)1.498 LitersStandard Error 0.0195
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post Dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=511, 256, 254)1.484 LitersStandard Error 0.0101
Secondary

Forced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 12 Hours Post-dose at Day 1 and Weeks 12 and 52

FEV1 was measured with spirometry conducted according to internationally accepted standards. Measurements were made at 5, 15, and 30 minutes; and 1, 2, 3, 4, 6, 8 10, and 12 hours post-dose. Standardized FEV1 AUC was calculated by the trapezoidal rule. The analysis included the same covariates as the primary Outcome Measure.

Time frame: From 5 minutes to 12 hours post-dose at Day 1 and Weeks 12 and 52

Population: Full Analysis Set (FAS), serial spirometry subgroup: A subgroup of approximately one third of all randomized patients who received at least 1 dose of study medication.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 12 Hours Post-dose at Day 1 and Weeks 12 and 52Week 12 (n=133, 69, 70)1.539 LitersStandard Error 0.0261
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 12 Hours Post-dose at Day 1 and Weeks 12 and 52Week 52 (n=125, 62, 58)1.492 LitersStandard Error 0.0265
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 12 Hours Post-dose at Day 1 and Weeks 12 and 52Day 11.566 LitersStandard Error 0.0168
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 12 Hours Post-dose at Day 1 and Weeks 12 and 52Week 12 (n=133, 69, 70)1.398 LitersStandard Error 0.0324
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 12 Hours Post-dose at Day 1 and Weeks 12 and 52Week 52 (n=125, 62, 58)1.364 LitersStandard Error 0.0352
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 12 Hours Post-dose at Day 1 and Weeks 12 and 52Day 11.407 LitersStandard Error 0.0207
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 12 Hours Post-dose at Day 1 and Weeks 12 and 52Week 52 (n=125, 62, 58)1.424 LitersStandard Error 0.0344
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 12 Hours Post-dose at Day 1 and Weeks 12 and 52Week 12 (n=133, 69, 70)1.505 LitersStandard Error 0.032
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 12 Hours Post-dose at Day 1 and Weeks 12 and 52Day 11.534 LitersStandard Error 0.0206
Secondary

Forced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 23 Hours 45 Minutes and From 12 Hours to 23 Hours 45 Minutes Post-dose at Weeks 12 and 52

FEV1 was measured with spirometry conducted according to internationally accepted standards. Measurements were made at 5, 15, and 30 minutes; 1, 2, 3, 4, 6, 8, 10, and 12 hours; 23 hours 15 minutes; and 23 hours 45 minutes post-dose. Standardized FEV1 AUC was calculated by the trapezoidal rule. The analysis included the same covariates as the primary Outcome Measure.

Time frame: From 5 minutes to 23 hours 45 minutes post-dose at Weeks 12 and 52

Population: Full Analysis Set (FAS), serial spirometry subgroup: A subgroup of approximately one third of all randomized patients who received at least 1 dose of study medication.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 23 Hours 45 Minutes and From 12 Hours to 23 Hours 45 Minutes Post-dose at Weeks 12 and 52Week 121.486 LitersStandard Error 0.0236
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 23 Hours 45 Minutes and From 12 Hours to 23 Hours 45 Minutes Post-dose at Weeks 12 and 52Week 52 (n=125, 62, 58)1.445 LitersStandard Error 0.0261
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 23 Hours 45 Minutes and From 12 Hours to 23 Hours 45 Minutes Post-dose at Weeks 12 and 52Week 121.380 LitersStandard Error 0.0298
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 23 Hours 45 Minutes and From 12 Hours to 23 Hours 45 Minutes Post-dose at Weeks 12 and 52Week 52 (n=125, 62, 58)1.339 LitersStandard Error 0.0346
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 23 Hours 45 Minutes and From 12 Hours to 23 Hours 45 Minutes Post-dose at Weeks 12 and 52Week 121.459 LitersStandard Error 0.0294
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 23 Hours 45 Minutes and From 12 Hours to 23 Hours 45 Minutes Post-dose at Weeks 12 and 52Week 52 (n=125, 62, 58)1.379 LitersStandard Error 0.0338
Secondary

Forced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52

FEV1 was measured with spirometry conducted according to internationally accepted standards. Measurements were made at 5, 15, and 30 minutes; and 1, 2, 3, and 4 hours post-dose. Standardized FEV1 AUC was calculated by the trapezoidal rule. The analysis included the same covariates as the primary Outcome Measure.

Time frame: From 5 minutes to 4 hours post-dose at Day 1 and Weeks 12, 26, and 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Week 52 (n=405, 192, 203)1.502 LitersStandard Error 0.0162
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Week 26 (n=430, 206, 216)1.546 LitersStandard Error 0.016
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Week 12 (n=460, 214, 232)1.560 LitersStandard Error 0.0134
Glycopyrronium Bromide 50 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Day 11.570 LitersStandard Error 0.0075
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Week 12 (n=460, 214, 232)1.384 LitersStandard Error 0.017
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Day 11.373 LitersStandard Error 0.0092
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Week 26 (n=430, 206, 216)1.369 LitersStandard Error 0.0194
Placebo to Glycopyrronium BromideForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Week 52 (n=405, 192, 203)1.336 LitersStandard Error 0.0203
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Week 26 (n=430, 206, 216)1.495 LitersStandard Error 0.019
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Day 11.514 LitersStandard Error 0.0092
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Week 12 (n=460, 214, 232)1.531 LitersStandard Error 0.0164
Tiotropium 18 μgForced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 4 Hours Post-dose at Day 1 and Weeks 12, 26, and 52Week 52 (n=405, 192, 203)1.487 LitersStandard Error 0.0196
Secondary

Forced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52

Just prior to FVC measurement, patients performed normal tidal breathing. The patient was given a few breaths warning before being told At the end of the next normal breath out, take a deep breath all the way in; they were then verbally encouraged to make a maximal effort before relaxing. The analysis included the same covariates as the primary Outcome Measure. Data was not collected at all time points for all Days and Weeks.

Time frame: 5, 15, and 30 minutes; 1, 2, 3, 4, 6, 8, 10, and 12 hours; 23 hours 15 minutes; and 23 hours 45 minutes post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52

Population: Full Analysis Set (FAS), serial spirometry subgroup: A subgroup of approximately one third of all randomized patients who received at least 1 dose of study medication.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=124, 65, 63)3.112 LitersStandard Error 0.0545
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=125, 64, 64)3.054 LitersStandard Error 0.0464
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=124, 64, 63)3.110 LitersStandard Error 0.0516
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=124, 64, 64)3.210 LitersStandard Error 0.0648
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=125, 62, 62)3.081 LitersStandard Error 0.0555
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=123, 61, 58)3.022 LitersStandard Error 0.0539
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=120, 60, 57)3.022 LitersStandard Error 0.0596
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=123, 60, 57)3.042 LitersStandard Error 0.0592
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=125, 62, 58)2.939 LitersStandard Error 0.0499
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=125, 62, 57)3.031 LitersStandard Error 0.0564
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=124, 61, 58)3.062 LitersStandard Error 0.0556
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 6 (n=118, 59, 54)2.986 LitersStandard Error 0.0614
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 10 (n=119, 59, 55)3.000 LitersStandard Error 0.0701
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 12 (n=120, 58, 52)2.881 LitersStandard Error 0.0631
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 16 (n=117, 53, 46)2.857 LitersStandard Error 0.0694
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=135, 74, 74)3.027 LitersStandard Error 0.0304
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=139, 75, 74)3.050 LitersStandard Error 0.0335
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 12 (n=130, 69, 70)3.030 LitersStandard Error 0.0444
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=136, 67, 70)3.165 LitersStandard Error 0.0501
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=135, 67, 70)3.248 LitersStandard Error 0.054
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=128, 66, 70)3.195 LitersStandard Error 0.0543
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=130, 67, 71)3.231 LitersStandard Error 0.0567
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=130, 69, 70)3.060 LitersStandard Error 0.0492
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=129, 67, 66)3.081 LitersStandard Error 0.0482
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=132, 67, 69)3.164 LitersStandard Error 0.0543
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=129, 65, 68)3.190 LitersStandard Error 0.0526
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=126, 64, 69)3.240 LitersStandard Error 0.0569
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 6 (n=123, 63, 69)3.158 LitersStandard Error 0.0594
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 10 (n=124, 61, 69)3.130 LitersStandard Error 0.0581
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=125, 65, 63)3.157 LitersStandard Error 0.0559
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (n=123, 62, 64)2.994 LitersStandard Error 0.0528
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=121, 61, 61)3.041 LitersStandard Error 0.0513
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=127, 64, 64)3.077 LitersStandard Error 0.052
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=124, 64, 62)3.111 LitersStandard Error 0.0551
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=120, 55, 61)3.056 LitersStandard Error 0.06
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=117, 56, 61)2.998 LitersStandard Error 0.0512
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=125, 62, 63)3.023 LitersStandard Error 0.0573
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=123, 62, 63)3.016 LitersStandard Error 0.0553
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=125, 62, 63)3.072 LitersStandard Error 0.0564
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=119, 61, 58)3.033 LitersStandard Error 0.0583
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=123, 61, 58)3.057 LitersStandard Error 0.0565
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=123, 60, 58)3.094 LitersStandard Error 0.0613
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=124, 60, 57)2.940 LitersStandard Error 0.0551
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=122, 59, 58)2.960 LitersStandard Error 0.0518
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=123, 62, 56)3.108 LitersStandard Error 0.0648
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=121, 60, 55)3.021 LitersStandard Error 0.0585
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 8 (n=119, 59, 54)2.961 LitersStandard Error 0.0646
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 22 (n=118, 60, 52)2.812 LitersStandard Error 0.067
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 15 minutes (n=121, 62, 57)2.888 LitersStandard Error 0.0595
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 45 minutes (n=122, 61, 57)2.855 LitersStandard Error 0.0558
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=143, 77, 74)3.055 LitersStandard Error 0.0343
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=144, 76, 75)3.148 LitersStandard Error 0.0377
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=144, 75, 75)3.179 LitersStandard Error 0.0373
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=143, 74, 73)3.190 LitersStandard Error 0.0433
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=144, 70, 74)3.138 LitersStandard Error 0.0414
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 6 (n=142, 71, 74)3.173 LitersStandard Error 0.0419
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 8 (n=137, 70, 75)3.071 LitersStandard Error 0.0404
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day1, hour 10 (n=134, 72, 75)3.134 LitersStandard Error 0.0414
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=129, 71, 72)2.991 LitersStandard Error 0.0385
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=128, 74, 75)3.014 LitersStandard Error 0.0364
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=135, 65, 73)3.051 LitersStandard Error 0.0439
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=133, 70, 72)3.103 LitersStandard Error 0.0443
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n= 139, 70, 74)3.134 LitersStandard Error 0.042
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=140, 68, 74)3.152 LitersStandard Error 0.0434
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=134, 66, 68)3.139 LitersStandard Error 0.043
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=130, 66, 71)3.167 LitersStandard Error 0.0507
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=133, 69, 67)3.058 LitersStandard Error 0.0479
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=124, 64, 68)3.119 LitersStandard Error 0.0576
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 8 (n=121, 64, 69)3.083 LitersStandard Error 0.0534
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 12 (n=122, 58, 68)3.072 LitersStandard Error 0.0599
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 16 (n=109, 56, 57)2.933 LitersStandard Error 0.0645
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 22 (n=117, 60, 63)2.924 LitersStandard Error 0.0517
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=126, 66, 67)3.091 LitersStandard Error 0.0548
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=124, 65, 63)3.055 LitersStandard Error 0.0507
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=123, 65, 64)3.156 LitersStandard Error 0.0608
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=124, 65, 65)3.156 LitersStandard Error 0.0576
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=125, 65, 65)3.198 LitersStandard Error 0.0552
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=125, 66, 63)3.093 LitersStandard Error 0.0526
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=125, 66, 63)2.781 LitersStandard Error 0.063
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=144, 76, 75)2.791 LitersStandard Error 0.046
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=125, 64, 64)2.700 LitersStandard Error 0.0597
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=123, 62, 63)2.731 LitersStandard Error 0.0691
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=127, 64, 64)2.678 LitersStandard Error 0.0658
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=125, 65, 65)2.815 LitersStandard Error 0.0676
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=126, 66, 67)2.862 LitersStandard Error 0.0676
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=124, 64, 63)2.771 LitersStandard Error 0.0655
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=125, 65, 63)2.778 LitersStandard Error 0.0677
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 6 (n=123, 63, 69)2.852 LitersStandard Error 0.0731
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=130, 66, 71)2.823 LitersStandard Error 0.0615
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=120, 55, 61)2.803 LitersStandard Error 0.0749
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=117, 56, 61)2.752 LitersStandard Error 0.0667
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=133, 70, 72)2.790 LitersStandard Error 0.0536
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=144, 75, 75)2.802 LitersStandard Error 0.046
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=125, 62, 62)2.687 LitersStandard Error 0.0715
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=125, 62, 63)2.703 LitersStandard Error 0.0707
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (n=123, 62, 64)2.700 LitersStandard Error 0.067
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=119, 61, 58)2.716 LitersStandard Error 0.0744
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=123, 60, 57)2.702 LitersStandard Error 0.0726
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 8 (n=121, 64, 69)2.760 LitersStandard Error 0.0657
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=123, 61, 58)2.695 LitersStandard Error 0.0706
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=128, 74, 75)2.817 LitersStandard Error 0.0444
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=123, 61, 58)2.723 LitersStandard Error 0.0734
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=124, 65, 65)2.801 LitersStandard Error 0.0695
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=120, 60, 57)2.731 LitersStandard Error 0.0727
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=143, 74, 73)2.826 LitersStandard Error 0.0526
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=123, 60, 58)2.731 LitersStandard Error 0.0749
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=121, 61, 61)2.692 LitersStandard Error 0.0652
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=124, 60, 57)2.645 LitersStandard Error 0.0701
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=135, 65, 73)2.793 LitersStandard Error 0.0553
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=132, 67, 69)2.737 LitersStandard Error 0.0663
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=144, 70, 74)2.783 LitersStandard Error 0.0515
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=124, 61, 58)2.714 LitersStandard Error 0.0689
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=122, 59, 58)2.640 LitersStandard Error 0.0675
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=121, 60, 55)2.694 LitersStandard Error 0.0724
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=125, 62, 58)2.625 LitersStandard Error 0.065
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=125, 62, 57)2.617 LitersStandard Error 0.0698
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 6 (n=118, 59, 54)2.690 LitersStandard Error 0.077
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=124, 64, 64)2.871 LitersStandard Error 0.0765
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 8 (n=119, 59, 54)2.637 LitersStandard Error 0.0793
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 10 (n=124, 61, 69)2.860 LitersStandard Error 0.0722
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 16 (n=109, 56, 57)2.701 LitersStandard Error 0.08
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 10 (n=119, 59, 55)2.687 LitersStandard Error 0.084
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=123, 62, 56)2.716 LitersStandard Error 0.0766
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 6 (n=142, 71, 74)2.846 LitersStandard Error 0.0514
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 12 (n=120, 58, 52)2.636 LitersStandard Error 0.0831
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=124, 64, 62)2.791 LitersStandard Error 0.0664
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 22 (n=118, 60, 52)2.604 LitersStandard Error 0.081
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 15 minutes (n=121, 62, 57)2.678 LitersStandard Error 0.0751
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=129, 65, 68)2.784 LitersStandard Error 0.0664
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=126, 64, 69)2.864 LitersStandard Error 0.0713
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 12 (n=122, 58, 68)2.771 LitersStandard Error 0.077
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 8 (n=137, 70, 75)2.804 LitersStandard Error 0.0506
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=139, 75, 74)2.802 LitersStandard Error 0.0403
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 16 (n=117, 53, 46)2.542 LitersStandard Error 0.0857
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=133, 69, 67)2.696 LitersStandard Error 0.0585
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 12 (n=130, 69, 70)2.709 LitersStandard Error 0.0535
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=129, 67, 66)2.740 LitersStandard Error 0.0588
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=123, 65, 64)2.864 LitersStandard Error 0.0719
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n= 139, 70, 74)2.825 LitersStandard Error 0.0519
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=140, 68, 74)2.770 LitersStandard Error 0.0537
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=124, 65, 63)2.826 LitersStandard Error 0.063
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=136, 67, 70)2.850 LitersStandard Error 0.0611
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=125, 62, 63)2.731 LitersStandard Error 0.0715
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day1, hour 10 (n=134, 72, 75)2.865 LitersStandard Error 0.0514
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=135, 67, 70)2.884 LitersStandard Error 0.0644
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=124, 64, 68)2.745 LitersStandard Error 0.0714
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 45 minutes (n=122, 61, 57)2.607 LitersStandard Error 0.07
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=128, 66, 70)2.826 LitersStandard Error 0.0644
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=135, 74, 74)2.826 LitersStandard Error 0.0363
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=124, 65, 63)2.770 LitersStandard Error 0.0655
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=130, 67, 71)2.821 LitersStandard Error 0.0675
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=143, 77, 74)2.752 LitersStandard Error 0.0416
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 22 (n=117, 60, 63)2.673 LitersStandard Error 0.0647
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=130, 69, 70)2.728 LitersStandard Error 0.0596
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=134, 66, 68)2.866 LitersStandard Error 0.0551
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=129, 71, 72)2.800 LitersStandard Error 0.0478
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=128, 74, 75)2.994 LitersStandard Error 0.0442
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=129, 67, 66)3.018 LitersStandard Error 0.0593
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=133, 69, 67)3.027 LitersStandard Error 0.0591
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=129, 71, 72)2.988 LitersStandard Error 0.0471
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 22 (n=117, 60, 63)2.870 LitersStandard Error 0.0629
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=129, 65, 68)3.155 LitersStandard Error 0.0649
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=124, 64, 68)3.084 LitersStandard Error 0.0686
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 8 (n=121, 64, 69)3.011 LitersStandard Error 0.0644
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 12 (n=122, 58, 68)3.020 LitersStandard Error 0.0722
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=124, 65, 63)3.029 LitersStandard Error 0.0666
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=125, 65, 63)3.050 LitersStandard Error 0.0688
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (n=123, 62, 64)2.954 LitersStandard Error 0.0658
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=133, 70, 72)3.103 LitersStandard Error 0.0536
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=126, 66, 67)3.110 LitersStandard Error 0.0671
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n= 139, 70, 74)3.078 LitersStandard Error 0.0513
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=124, 64, 62)3.086 LitersStandard Error 0.0664
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=125, 65, 65)3.112 LitersStandard Error 0.0679
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=120, 55, 61)2.932 LitersStandard Error 0.0721
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=125, 62, 63)2.881 LitersStandard Error 0.0706
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=123, 62, 63)2.898 LitersStandard Error 0.0683
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=125, 62, 62)2.971 LitersStandard Error 0.0708
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=134, 66, 68)3.071 LitersStandard Error 0.0534
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=124, 65, 63)3.004 LitersStandard Error 0.0638
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=123, 61, 58)3.098 LitersStandard Error 0.0734
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=120, 60, 57)2.963 LitersStandard Error 0.0726
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=123, 60, 57)2.937 LitersStandard Error 0.0725
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=130, 66, 71)3.101 LitersStandard Error 0.0603
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=121, 61, 61)2.976 LitersStandard Error 0.0644
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=124, 60, 57)2.860 LitersStandard Error 0.0702
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=125, 62, 57)2.980 LitersStandard Error 0.0704
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=132, 67, 69)3.098 LitersStandard Error 0.0655
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=123, 62, 56)3.053 LitersStandard Error 0.0779
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 12 (n=120, 58, 52)2.849 LitersStandard Error 0.0847
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 16 (n=117, 53, 46)2.772 LitersStandard Error 0.0873
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=126, 64, 69)3.146 LitersStandard Error 0.0685
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 22 (n=118, 60, 52)2.716 LitersStandard Error 0.0827
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=123, 65, 64)3.104 LitersStandard Error 0.0723
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 15 minutes (n=121, 62, 57)2.852 LitersStandard Error 0.0755
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 6 (n=123, 63, 69)3.120 LitersStandard Error 0.07
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=143, 77, 74)2.979 LitersStandard Error 0.0422
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=125, 64, 64)2.994 LitersStandard Error 0.0589
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=127, 64, 64)3.016 LitersStandard Error 0.0651
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=144, 76, 75)3.041 LitersStandard Error 0.0463
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=124, 64, 63)3.080 LitersStandard Error 0.065
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 10 (n=124, 61, 69)3.117 LitersStandard Error 0.0692
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=124, 64, 64)3.176 LitersStandard Error 0.0762
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=117, 56, 61)2.895 LitersStandard Error 0.0646
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=125, 62, 63)2.963 LitersStandard Error 0.0699
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=119, 61, 58)3.069 LitersStandard Error 0.0746
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=144, 75, 75)3.049 LitersStandard Error 0.0461
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=123, 61, 58)3.065 LitersStandard Error 0.0699
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=123, 60, 58)2.985 LitersStandard Error 0.0747
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=122, 59, 58)2.935 LitersStandard Error 0.0666
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=143, 74, 73)3.119 LitersStandard Error 0.0531
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=125, 62, 58)2.929 LitersStandard Error 0.0652
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=124, 65, 65)3.082 LitersStandard Error 0.0699
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=124, 61, 58)3.021 LitersStandard Error 0.0689
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=121, 60, 55)2.978 LitersStandard Error 0.0735
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=144, 70, 74)3.102 LitersStandard Error 0.0512
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 6 (n=118, 59, 54)2.982 LitersStandard Error 0.0781
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 8 (n=119, 59, 54)2.942 LitersStandard Error 0.0805
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 10 (n=119, 59, 55)3.012 LitersStandard Error 0.0844
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 6 (n=142, 71, 74)3.148 LitersStandard Error 0.0513
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, 45 minutes (n=122, 61, 57)2.797 LitersStandard Error 0.0702
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 16 (n=109, 56, 57)2.880 LitersStandard Error 0.0785
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=135, 74, 74)2.956 LitersStandard Error 0.0363
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=139, 75, 74)2.991 LitersStandard Error 0.0406
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 8 (n=137, 70, 75)3.074 LitersStandard Error 0.0498
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=135, 65, 73)3.014 LitersStandard Error 0.0534
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=140, 68, 74)3.060 LitersStandard Error 0.0528
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=125, 66, 63)2.993 LitersStandard Error 0.0643
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=136, 67, 70)3.092 LitersStandard Error 0.0602
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=135, 67, 70)3.180 LitersStandard Error 0.0636
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day1, hour 10 (n=134, 72, 75)3.119 LitersStandard Error 0.051
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=128, 66, 70)3.097 LitersStandard Error 0.0632
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 12 (n=130, 69, 70)3.012 LitersStandard Error 0.0537
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=130, 67, 71)3.149 LitersStandard Error 0.0664
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; 1, 2, 3, 4, 6, 8, 10, and 12 Hours; 23 Hours 15 Minutes; and 23 Hours 45 Minutes Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=130, 69, 70)3.023 LitersStandard Error 0.0596
Secondary

Forced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52

Just prior to FVC measurement, patients performed normal tidal breathing. The patient was given a few breaths warning before being told At the end of the next normal breath out, take a deep breath all the way in; they were then verbally encouraged to make a maximal effort before relaxing. The analysis included the same covariates as the primary Outcome Measure. Data was not collected at all time points for all Days and Weeks.

Time frame: 5, 15, and 30 minutes; and 1, 2, 3, 4 hours post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=455, 210, 227)3.062 LitersStandard Error 0.0267
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=401, 188, 197)2.899 LitersStandard Error 0.0309
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=401, 185, 198)2.952 LitersStandard Error 0.0305
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=446, 207, 225)3.093 LitersStandard Error 0.0266
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=474, 239, 232)2.930 LitersStandard Error 0.0178
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=405, 187, 202)2.971 LitersStandard Error 0.0321
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=444, 204, 225)3.129 LitersStandard Error 0.0275
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=437, 202, 224)3.050 LitersStandard Error 0.0278
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=511, 256, 254)3.074 LitersStandard Error 0.0173
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=416, 203, 208)3.022 LitersStandard Error 0.0312
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=430, 200, 214)2.991 LitersStandard Error 0.0282
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=416, 204, 213)3.097 LitersStandard Error 0.0331
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=426, 195, 205)2.977 LitersStandard Error 0.0268
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=480, 223, 234)3.085 LitersStandard Error 0.0243
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=420, 203, 208)3.049 LitersStandard Error 0.0308
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=429, 207, 218)3.016 LitersStandard Error 0.0301
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=498, 223, 243)2.984 LitersStandard Error 0.0222
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=425, 206, 212)3.034 LitersStandard Error 0.0293
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=428, 209, 219)3.029 LitersStandard Error 0.0293
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=502, 255, 254)2.982 LitersStandard Error 0.0164
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=424, 206, 213)2.983 LitersStandard Error 0.0282
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=433, 209, 220)3.063 LitersStandard Error 0.0298
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=414, 200, 207)2.980 LitersStandard Error 0.0298
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=430, 206, 218)2.985 LitersStandard Error 0.0286
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=487, 229, 239)3.016 LitersStandard Error 0.022
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (421, 202, 213)2.956 LitersStandard Error 0.0289
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=430, 207, 220)3.020 LitersStandard Error 0.0293
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=431, 207, 221)3.058 LitersStandard Error 0.0309
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=400, 186, 199)3.029 LitersStandard Error 0.0359
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=495, 255, 253)2.915 LitersStandard Error 0.0145
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n=503, 233, 242)3.028 LitersStandard Error 0.0212
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=513, 253, 252)3.119 LitersStandard Error 0.0182
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=394, 183, 200)2.942 LitersStandard Error 0.0314
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=501, 229, 240)3.068 LitersStandard Error 0.0213
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 45 (n=395, 185, 199)2.869 LitersStandard Error 0.0342
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=392, 186, 204)2.999 LitersStandard Error 0.0342
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=476, 221, 231)3.004 LitersStandard Error 0.0215
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=402, 186, 202)2.997 LitersStandard Error 0.0354
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=391, 187, 203)2.971 LitersStandard Error 0.033
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=479, 222, 234)3.024 LitersStandard Error 0.0234
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=510, 248, 252)3.129 LitersStandard Error 0.0193
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=386, 185, 199)2.925 LitersStandard Error 0.0328
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 15 (n=388, 183, 198)2.866 LitersStandard Error 0.0349
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=405, 189, 201)3.016 LitersStandard Error 0.0345
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=454, 217, 227)3.047 LitersStandard Error 0.0262
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=404, 190, 201)2.992 LitersStandard Error 0.0339
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=405, 188, 201)3.001 LitersStandard Error 0.0336
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=459, 220, 225)3.050 LitersStandard Error 0.0257
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=504, 239, 250)3.076 LitersStandard Error 0.0192
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=398, 189, 199)2.982 LitersStandard Error 0.0344
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=460, 220, 226)3.079 LitersStandard Error 0.0265
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=507, 252, 254)3.004 LitersStandard Error 0.0177
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=412, 195, 215)3.014 LitersStandard Error 0.0336
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=453, 212, 230)2.991 LitersStandard Error 0.0253
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=402, 189, 202)2.923 LitersStandard Error 0.0325
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=410, 196, 215)3.002 LitersStandard Error 0.0333
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=448, 205, 222)3.003 LitersStandard Error 0.0252
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=481, 243, 239)2.926 LitersStandard Error 0.0178
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=407, 191, 214)2.983 LitersStandard Error 0.0327
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=455, 212, 226)2.985 LitersStandard Error 0.0251
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=397, 184, 199)2.984 LitersStandard Error 0.0359
Glycopyrronium Bromide 50 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=408, 194, 212)2.967 LitersStandard Error 0.0321
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=405, 189, 201)2.734 LitersStandard Error 0.0419
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=502, 255, 254)2.719 LitersStandard Error 0.0199
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=511, 256, 254)2.732 LitersStandard Error 0.0214
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=513, 253, 252)2.762 LitersStandard Error 0.0227
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=510, 248, 252)2.811 LitersStandard Error 0.0243
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=504, 239, 250)2.767 LitersStandard Error 0.0244
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=481, 243, 239)2.745 LitersStandard Error 0.022
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=474, 239, 232)2.749 LitersStandard Error 0.0221
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=498, 223, 243)2.760 LitersStandard Error 0.0282
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=487, 229, 239)2.748 LitersStandard Error 0.0274
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n=503, 233, 242)2.756 LitersStandard Error 0.0269
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=501, 229, 240)2.757 LitersStandard Error 0.0271
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=476, 221, 231)2.768 LitersStandard Error 0.0277
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=479, 222, 234)2.771 LitersStandard Error 0.0294
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=480, 223, 234)2.804 LitersStandard Error 0.0305
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=454, 217, 227)2.767 LitersStandard Error 0.0313
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=459, 220, 225)2.764 LitersStandard Error 0.0312
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=460, 220, 226)2.768 LitersStandard Error 0.0322
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=453, 212, 230)2.726 LitersStandard Error 0.0313
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=448, 205, 222)2.735 LitersStandard Error 0.0316
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=455, 212, 226)2.707 LitersStandard Error 0.0314
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=455, 210, 227)2.741 LitersStandard Error 0.0333
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=446, 207, 225)2.801 LitersStandard Error 0.0335
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=437, 202, 224)2.793 LitersStandard Error 0.0349
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=426, 195, 205)2.799 LitersStandard Error 0.0336
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=429, 207, 218)2.753 LitersStandard Error 0.0362
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=428, 209, 219)2.737 LitersStandard Error 0.0353
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=430, 206, 218)2.744 LitersStandard Error 0.0349
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=431, 207, 221)2.774 LitersStandard Error 0.0374
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (421, 202, 213)2.733 LitersStandard Error 0.0352
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=414, 200, 207)2.713 LitersStandard Error 0.0363
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=424, 206, 213)2.715 LitersStandard Error 0.0342
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=425, 206, 212)2.721 LitersStandard Error 0.0352
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=420, 203, 208)2.777 LitersStandard Error 0.037
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=416, 204, 213)2.831 LitersStandard Error 0.0389
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=416, 203, 208)2.776 LitersStandard Error 0.0369
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=405, 187, 202)2.758 LitersStandard Error 0.0387
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=401, 185, 198)2.759 LitersStandard Error 0.0373
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=408, 194, 212)2.713 LitersStandard Error 0.0387
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=407, 191, 214)2.718 LitersStandard Error 0.0392
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=410, 196, 215)2.690 LitersStandard Error 0.04
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=412, 195, 215)2.711 LitersStandard Error 0.04
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=398, 189, 199)2.727 LitersStandard Error 0.0415
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=405, 188, 201)2.713 LitersStandard Error 0.041
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=495, 255, 253)2.731 LitersStandard Error 0.0174
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=386, 185, 199)2.729 LitersStandard Error 0.0393
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=391, 187, 203)2.729 LitersStandard Error 0.0398
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=392, 186, 204)2.731 LitersStandard Error 0.0409
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=394, 183, 200)2.701 LitersStandard Error 0.0389
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=507, 252, 254)2.692 LitersStandard Error 0.0219
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=444, 204, 225)2.839 LitersStandard Error 0.0346
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=430, 200, 214)2.799 LitersStandard Error 0.0349
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=433, 209, 220)2.747 LitersStandard Error 0.0359
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=430, 207, 220)2.749 LitersStandard Error 0.0356
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=401, 188, 197)2.673 LitersStandard Error 0.0377
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=402, 189, 202)2.666 LitersStandard Error 0.0391
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=404, 190, 201)2.696 LitersStandard Error 0.0405
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=402, 186, 202)2.727 LitersStandard Error 0.0421
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=400, 186, 199)2.742 LitersStandard Error 0.0427
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=397, 184, 199)2.725 LitersStandard Error 0.0425
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 15 (n=388, 183, 198)2.675 LitersStandard Error 0.0419
Placebo to Glycopyrronium BromideForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 45 (n=395, 185, 199)2.694 LitersStandard Error 0.0406
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 5 (n=401, 188, 197)2.916 LitersStandard Error 0.0367
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 15 (n=407, 191, 214)2.948 LitersStandard Error 0.0376
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 5 (n=453, 212, 230)2.978 LitersStandard Error 0.0304
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 15 (n=394, 183, 200)2.969 LitersStandard Error 0.0371
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 30 (n=410, 196, 215)2.947 LitersStandard Error 0.0386
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 30 (n=460, 220, 226)3.079 LitersStandard Error 0.0319
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 4 (n=504, 239, 250)3.031 LitersStandard Error 0.0237
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, hour 1 (n=412, 195, 215)2.959 LitersStandard Error 0.0385
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 15 (n=459, 220, 225)3.046 LitersStandard Error 0.0311
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 15 (n=502, 255, 254)2.903 LitersStandard Error 0.0198
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 5 (n=398, 189, 199)2.983 LitersStandard Error 0.0406
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 9, minute 5 (n=454, 217, 227)3.029 LitersStandard Error 0.0309
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, minute 30 (n=402, 189, 202)2.962 LitersStandard Error 0.0378
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 15 (n=405, 188, 201)3.001 LitersStandard Error 0.0398
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 30 (n=480, 223, 234)3.063 LitersStandard Error 0.0297
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 3 (n=510, 248, 252)3.073 LitersStandard Error 0.0239
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 42, minute 30 (n=405, 189, 201)3.021 LitersStandard Error 0.0408
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 15 (n=479, 222, 234)3.024 LitersStandard Error 0.0286
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 45 (n=395, 185, 199)2.868 LitersStandard Error 0.039
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 5, minute 5 (n=476, 221, 231)3.011 LitersStandard Error 0.027
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 1 (n=404, 190, 201)3.011 LitersStandard Error 0.0393
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 15 (n=391, 187, 203)2.962 LitersStandard Error 0.0384
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, hour 1 (n=501, 229, 240)3.023 LitersStandard Error 0.0267
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 2 (n=513, 253, 252)3.033 LitersStandard Error 0.0226
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 30 (n=503, 233, 242)3.018 LitersStandard Error 0.0265
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 23, minute 15 (n=388, 183, 198)2.865 LitersStandard Error 0.0402
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 15 (n=487, 229, 239)3.030 LitersStandard Error 0.027
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 2 (n=402, 186, 202)3.005 LitersStandard Error 0.0405
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 15 (n=430, 207, 220)2.994 LitersStandard Error 0.0345
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 15, minute 5 (n=498, 223, 243)2.980 LitersStandard Error 0.0272
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 30 (n=431, 207, 221)3.028 LitersStandard Error 0.0362
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 20, minute 5 (n=430, 206, 218)2.966 LitersStandard Error 0.0338
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 45 (n=474, 239, 232)2.923 LitersStandard Error 0.0224
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 5 (421, 202, 213)2.945 LitersStandard Error 0.0345
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 30 (n=433, 209, 220)3.036 LitersStandard Error 0.0353
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 1 (n=511, 256, 254)2.975 LitersStandard Error 0.0213
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 15 (n=414, 200, 207)2.959 LitersStandard Error 0.036
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 15 (n=428, 209, 219)3.002 LitersStandard Error 0.0348
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 3 (n=444, 204, 225)3.096 LitersStandard Error 0.0332
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, minute 30 (n=424, 206, 213)2.949 LitersStandard Error 0.0337
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 16, minute 5 (n=429, 207, 218)3.009 LitersStandard Error 0.0355
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 4 (n=397, 184, 199)2.991 LitersStandard Error 0.041
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 1 (n=425, 206, 212)2.997 LitersStandard Error 0.0346
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 45 (n=426, 195, 205)2.946 LitersStandard Error 0.0332
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 52, hour 3 (n=400, 186, 199)3.020 LitersStandard Error 0.0413
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 2 (n=420, 203, 208)3.036 LitersStandard Error 0.0366
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 23, minute 15 (n=430, 200, 214)2.985 LitersStandard Error 0.0341
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 30 (n=507, 252, 254)2.937 LitersStandard Error 0.0217
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 3 (n=416, 204, 213)3.065 LitersStandard Error 0.0381
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 4 (n=437, 202, 224)3.054 LitersStandard Error 0.0333
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 5 (n=386, 185, 199)2.942 LitersStandard Error 0.0381
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 4 (n=416, 203, 208)3.021 LitersStandard Error 0.0364
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 2 (n=446, 207, 225)3.065 LitersStandard Error 0.0324
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 50, minute 30 (n=392, 186, 204)2.998 LitersStandard Error 0.0394
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 15 (n=405, 187, 202)2.901 LitersStandard Error 0.0379
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, hour 1 (n=455, 210, 227)3.048 LitersStandard Error 0.0322
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, hour 23, minute 15 (n=481, 243, 239)2.923 LitersStandard Error 0.022
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 26, hour 23, minute 45 (n=401, 185, 198)2.883 LitersStandard Error 0.0368
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 30 (n=455, 212, 226)2.987 LitersStandard Error 0.0306
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Day 1, minute 5 (n=495, 255, 253)2.856 LitersStandard Error 0.0174
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 34, minute 5 (n=408, 194, 212)2.919 LitersStandard Error 0.0374
Tiotropium 18 μgForced Vital Capacity (FVC) 5, 15, and 30 Minutes; and 1, 2, 3, and 4 Hours Post-dose at Days 1 and 15; and Weeks 5, 9, 12, 16, 20, 26, 34, 42, 50, and 52Week 12, minute 15 (n=448, 205, 222)3.004 LitersStandard Error 0.0307
Secondary

Health-related Quality of Life (QoL) Assessed With the St. George Respiratory Questionnaire (SGRQ) at Week 52

The SGRQ contained 51 patient-rated items divided into three components: Symptoms (respiratory symptoms, their frequency, and severity), Activity (activities that cause or are limited by breathlessness), and Impacts (social functioning and psychological disturbances resulting from airway disease). A total score for the 3 components was calculated and ranged from 0 to 100. Higher values indicate greater impairment of QoL. The analysis included the same covariates as the primary Outcome Measure.

Time frame: Week 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgHealth-related Quality of Life (QoL) Assessed With the St. George Respiratory Questionnaire (SGRQ) at Week 5240.85 Units on a scaleStandard Error 0.854
Placebo to Glycopyrronium BromideHealth-related Quality of Life (QoL) Assessed With the St. George Respiratory Questionnaire (SGRQ) at Week 5244.16 Units on a scaleStandard Error 1.04
Tiotropium 18 μgHealth-related Quality of Life (QoL) Assessed With the St. George Respiratory Questionnaire (SGRQ) at Week 5241.32 Units on a scaleStandard Error 1.024
Secondary

Number of Moderate or Severe Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) Per Year During the Study (Baseline to Week 52)

The number of moderate or severe exacerbations of COPD per year during the study was calculated by dividing the total number of exacerbations during the study by the total number of years of treatment. A COPD exacerbation was considered to be moderate if treatment with systemic corticosteroids and/or antibiotic was required. A COPD exacerbation was considered to be severe if treatment for moderate severity and hospitalization was required.

Time frame: Baseline to Week 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureValue (NUMBER)
Glycopyrronium Bromide 50 μgNumber of Moderate or Severe Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) Per Year During the Study (Baseline to Week 52)0.54 Exacerbations per treatment year
Placebo to Glycopyrronium BromideNumber of Moderate or Severe Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) Per Year During the Study (Baseline to Week 52)0.80 Exacerbations per treatment year
Tiotropium 18 μgNumber of Moderate or Severe Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) Per Year During the Study (Baseline to Week 52)0.62 Exacerbations per treatment year
Secondary

Percentage of Days Able to Perform Usual Daily Activities During the Study (Baseline to Week 52)

A day able to perform usual daily activities was defined as any day where the patient recorded in their electronic diary in the evening that they were not prevented from performing their usual daily activities due to respiratory symptoms during the previous 12 hours. The percentage of days able to perform usual daily activities was calculated as the total number of days able to perform usual daily activities over the 52 week treatment period divided by the total number of days where diary recordings were made.

Time frame: Baseline to Week 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgPercentage of Days Able to Perform Usual Daily Activities During the Study (Baseline to Week 52)38.02 Percentage of daysStandard Error 1.883
Placebo to Glycopyrronium BromidePercentage of Days Able to Perform Usual Daily Activities During the Study (Baseline to Week 52)36.18 Percentage of daysStandard Error 2.27
Tiotropium 18 μgPercentage of Days Able to Perform Usual Daily Activities During the Study (Baseline to Week 52)38.09 Percentage of daysStandard Error 2.259
Secondary

Percentage of Days With no Daytime Symptoms During the Study (Baseline to Week 52)

A day with no daytime symptoms was defined as any day where the patient recorded no cough, no wheeze, no production of sputum, no feeling of breathlessness (other than when running), and no puffs of rescue medication during the previous 12 hours in evening entry in the electronic patient diary. The percentage of days with no daytime symptoms was calculated as the total number of days with no daytime symptoms over the 52 week treatment period divided by the total number of days where diary recordings were made.

Time frame: Baseline to Week 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgPercentage of Days With no Daytime Symptoms During the Study (Baseline to Week 52)6.54 Percentage of daysStandard Error 1.208
Placebo to Glycopyrronium BromidePercentage of Days With no Daytime Symptoms During the Study (Baseline to Week 52)3.81 Percentage of daysStandard Error 1.431
Tiotropium 18 μgPercentage of Days With no Daytime Symptoms During the Study (Baseline to Week 52)7.14 Percentage of daysStandard Error 1.424
Secondary

Percentage of Nights With no Nighttime Awakenings During the Study (Baseline to Week 52)

A night with no nighttime awakenings was defined as any night where the patient did not wake up due to 1 or more of 6 symptoms (respiratory symptoms, cough, wheeze, amount of sputum, color of sputum, and breathlessness). Symptoms occurring during the previous 12 hours were recorded each morning and evening by the patient in an electronic diary. The percentage of nights with 'no nighttime awakenings' was calculated as the total number of nights with no nighttime awakenings over the 52 week treatment period divided by the total number of nights where diary recordings were made.

Time frame: Baseline to Week 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgPercentage of Nights With no Nighttime Awakenings During the Study (Baseline to Week 52)57.36 Percentage of nightsStandard Error 1.842
Placebo to Glycopyrronium BromidePercentage of Nights With no Nighttime Awakenings During the Study (Baseline to Week 52)52.15 Percentage of nightsStandard Error 2.239
Tiotropium 18 μgPercentage of Nights With no Nighttime Awakenings During the Study (Baseline to Week 52)55.47 Percentage of nightsStandard Error 2.23
Secondary

Percentage of Patients Who Experienced a Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbation During the Study (Baseline to Week 52)

A COPD exacerbation was considered to be moderate if treatment with systemic corticosteroids and/or antibiotic was required. A COPD exacerbation was considered to be severe if treatment for moderate severity and hospitalization was required.

Time frame: Baseline to Week 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureValue (NUMBER)
Glycopyrronium Bromide 50 μgPercentage of Patients Who Experienced a Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbation During the Study (Baseline to Week 52)32.8 Percentage of participants
Placebo to Glycopyrronium BromidePercentage of Patients Who Experienced a Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbation During the Study (Baseline to Week 52)40.2 Percentage of participants
Tiotropium 18 μgPercentage of Patients Who Experienced a Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbation During the Study (Baseline to Week 52)30.1 Percentage of participants
Secondary

Time to First Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbation During the Study (Baseline to Week 52)

Time to first moderate or severe COPD exacerbation was calculated as the number of days from baseline to the day on which the patient experienced the first moderate or severe COPD exacerbation. A COPD exacerbation was considered to be moderate if treatment with systemic corticosteroids and/or antibiotic was required. A COPD exacerbation was considered to be severe if treatment for moderate severity and hospitalization was required.

Time frame: Baseline to Week 52 (patients with no moderate or severe exacerbations who completed the study were censored at the final visit date, which may have exceeded 52 weeks)

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureValue (MEDIAN)
Glycopyrronium Bromide 50 μgTime to First Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbation During the Study (Baseline to Week 52)363.0 Days
Placebo to Glycopyrronium BromideTime to First Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbation During the Study (Baseline to Week 52)231.0 Days
Tiotropium 18 μgTime to First Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbation During the Study (Baseline to Week 52)364.0 Days
Secondary

Transition Dyspnea Index (TDI) at Week 26

The TDI measured changes in dyspnea from baseline during treatment and included 3 domains: Functional impairment (activities of daily living), magnitude of task (intensity of activity), and magnitude of effort (difficulty breathing). Each domain was rated from -3 to 3 (major deterioration-major improvement). The total score ranged from -9 to 9; minus scores indicate deterioration. The analysis included the same covariates as the primary Outcome Measure.

Time frame: Week 26

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgTransition Dyspnea Index (TDI) at Week 262.13 Units on a scaleStandard Error 0.24
Placebo to Glycopyrronium BromideTransition Dyspnea Index (TDI) at Week 261.32 Units on a scaleStandard Error 0.289
Tiotropium 18 μgTransition Dyspnea Index (TDI) at Week 262.26 Units on a scaleStandard Error 0.281
Secondary

Trough Forced Expiratory Volume in 1 Second (FEV1) at Day 1, Week 26, and Week 52

FEV1 was measured with spirometry conducted according to internationally accepted standards. Trough FEV1 was defined as the average of measurements made 23 hours 15 minutes and 23 hours 45 minutes post-dose. The analysis included the same covariates as the primary Outcome Measure.

Time frame: Day 1, Week 26, and Week 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgTrough Forced Expiratory Volume in 1 Second (FEV1) at Day 1, Week 26, and Week 52Week 52 (n=416, 196, 210)1.412 LitersStandard Error 0.0157
Glycopyrronium Bromide 50 μgTrough Forced Expiratory Volume in 1 Second (FEV1) at Day 1, Week 26, and Week 52Week 26 (n=451, 219, 233)1.458 LitersStandard Error 0.0161
Glycopyrronium Bromide 50 μgTrough Forced Expiratory Volume in 1 Second (FEV1) at Day 1, Week 26, and Week 52Day 11.478 LitersStandard Error 0.0088
Placebo to Glycopyrronium BromideTrough Forced Expiratory Volume in 1 Second (FEV1) at Day 1, Week 26, and Week 52Week 52 (n=416, 196, 210)1.303 LitersStandard Error 0.0198
Placebo to Glycopyrronium BromideTrough Forced Expiratory Volume in 1 Second (FEV1) at Day 1, Week 26, and Week 52Week 26 (n=451, 219, 233)1.324 LitersStandard Error 0.0196
Placebo to Glycopyrronium BromideTrough Forced Expiratory Volume in 1 Second (FEV1) at Day 1, Week 26, and Week 52Day 11.388 LitersStandard Error 0.0109
Tiotropium 18 μgTrough Forced Expiratory Volume in 1 Second (FEV1) at Day 1, Week 26, and Week 52Week 26 (n=451, 219, 233)1.408 LitersStandard Error 0.0191
Tiotropium 18 μgTrough Forced Expiratory Volume in 1 Second (FEV1) at Day 1, Week 26, and Week 52Day 11.471 LitersStandard Error 0.0109
Tiotropium 18 μgTrough Forced Expiratory Volume in 1 Second (FEV1) at Day 1, Week 26, and Week 52Week 52 (n=416, 196, 210)1.392 LitersStandard Error 0.0191
Secondary

Trough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52

Trough FVC is defined as the average of the post-dose 23 h 15 min and the 23 h 45 min FVC values. Just prior to FVC measurement, patients performed normal tidal breathing. The patient was given a few breaths warning before being told At the end of the next normal breath out, take a deep breath all the way in; they were then verbally encouraged to make a maximal effort before relaxing. The analysis included the same covariates as the primary Outcome Measure.

Time frame: Day 1, Week 12, Week 26, and Week 52

Population: Full Analysis Set (FAS): All randomized patients who received at least 1 dose of study medication.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Glycopyrronium Bromide 50 μgTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Day 12.936 LitersStandard Error 0.0165
Glycopyrronium Bromide 50 μgTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Week 12 (n=442, 204, 217)2.985 LitersStandard Error 0.0265
Glycopyrronium Bromide 50 μgTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Week 52 (n=395, 186, 201)2.866 LitersStandard Error 0.0335
Glycopyrronium Bromide 50 μgTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Week 26 (n=418, 196, 208)2.962 LitersStandard Error 0.0299
Placebo to Glycopyrronium BromideTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Week 12 (n=442, 204, 217)2.802 LitersStandard Error 0.0329
Placebo to Glycopyrronium BromideTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Week 26 (n=418, 196, 208)2.758 LitersStandard Error 0.0361
Placebo to Glycopyrronium BromideTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Day 12.757 LitersStandard Error 0.0205
Placebo to Glycopyrronium BromideTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Week 52 (n=395, 186, 201)2.687 LitersStandard Error 0.0399
Tiotropium 18 μgTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Week 52 (n=395, 186, 201)2.866 LitersStandard Error 0.0383
Tiotropium 18 μgTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Week 12 (n=442, 204, 217)2.970 LitersStandard Error 0.0323
Tiotropium 18 μgTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Day 12.930 LitersStandard Error 0.0206
Tiotropium 18 μgTrough Forced Vital Capacity (FVC) at Day 1, Week 12, Week 26, and Week 52Week 26 (n=418, 196, 208)2.892 LitersStandard Error 0.0355

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026